AcelRx Pharmaceuticals, Inc. (ACRX) Social Stream
ACELRX PHARMACEUTICALS INC (ACRX) Price Targets From Analysts
Use the tables below to see what analysts covering ACELRX PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-17 | 3 | $9 | $4 | $6 | $0.768 | 681.25% |
| 2021-11-16 | 3 | $9 | $4 | $5.833 | $0.768 | 659.51% |
| 2021-12-02 | 2 | $4.5 | $4 | $4.166 | $0.768 | 442.45% |
| 2022-03-11 | 3 | $4.5 | $4 | $4.166 | $0.768 | 442.45% |
| 2022-08-12 | 2 | $4 | $4 | $4 | $0.768 | 420.83% |
| 2022-11-15 | 1 | $80 | $80 | $80 | $0.768 | 10316.67% |
| 2023-04-03 | 2 | $80 | $80 | $80 | $0.768 | 10316.67% |
| 2023-08-18 | 1 | $8 | $8 | $8 | $0.768 | 941.67% |
| 2023-09-25 | 1 | $5 | $5 | $5 | $0.768 | 551.04% |
| 2023-11-09 | 1 | $5 | $4.25 | $4.625 | $0.768 | 502.21% |
| NA | 1 | $NA | $NA | $NA | $0.768 | NA% |
Price Target Last Issued August 18, 2023
The Trend in the Analyst Price Target
ACRX's average price target has moved down $1.38 over the prior 26 months.
Over the past 31 weeks, ACRX's average upside potential has been 3,238.45%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-03 | 2 | 80 | 80.00 | 80.000 | 0.610 | 13014.75% |
| 2023-08-18 | 1 | 8 | 8.00 | 8.000 | 0.869 | 820.6% |
| 2023-09-25 | 1 | 5 | 5.00 | 5.000 | 0.601 | 731.95% |
| 2023-10-02 | 1 | 5 | 4.25 | 4.625 | 0.550 | 740.91% |
| 2023-11-09 | 1 | 5 | 4.25 | 4.625 | 0.470 | 884.04% |
ACRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
ACRX's average broker recommendation rating improved by 1 over the prior 15 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ACELRX PHARMACEUTICALS INC's number of analysts covering the stock is greater than 30.63% of all US stocks.
- ACRX has a greater upside potential (average analyst target price relative to current price) than 957.38% of all US stocks.
- In terms of how ACELRX PHARMACEUTICALS INC fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -59.42% of that group.
- ACRX has a greater average analyst price target than 280.64% of stocks in the small market cap category.
Stocks similar to ACELRX PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IBIO, AMPE, and VTGN.
View All Top Stocks by Price Target
What is the outlook for ACRX? Use POWR Ratings for clearer insight into price direction.